CTRI/2020/12/029494已完成未知
An Ayurvedic management of Jalodara(Hepatic cirrhosis complicated with ascites.)
J S Ayurveda Mahavidyalaya0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients fulfilling the diagnistic criteria as signs and symptoms of ascites due to Hepatic cirrhosis i.e. ascites, oedema, palmer errythma, loss of appetite, general weakness, nausea and vomiting
- •Abnormal liver function tests i.e. hypoalbuminemia, altered A:G ratio, raised SGPT and SGOT
- •Alcoholic and Nonalcoholic patients
排除标准
- •1)Hepatic cirrhosis due to cardic causes, inherited metabolic causes, haemocromatosis and wilsonââ?¬•s disease.
- •2) Life threatening complications (like encephalopathy and excessive gastrointestinal bleeding ) and other major co-morbidities (like insulin dependent diabetes mellitus, manifest heart diseases, renal failure)
- •3)Female patients having pregnancy, post delivery period or lactation period
- •4)Patients who are taking any psychiatric or other liver damaging medicines.
研究者
相似试验
已完成
不适用
A Novel Experience in Treatment of Liver Hydatidosis in Pediatricspataient with hepatic hydatid cysts underwent PAHSI treatment:The consecutive steps including sonographic guidance,aspiration of cyst content and injection of 15% saline hypertonic were carried ouTCTR20170821006Mashhad University of Medical Sciences81
招募中
不适用
Clinical course of liver cirrhosis and liver cirrhosis complicationsK74.6K70.3Other and unspecified cirrhosis of liverAlcoholic cirrhosis of liverDRKS00013117niversitätsmedizin der Johannes Gutenberg-Universität Mainz500
已完成
不适用
A treatment algorithm for Hepatic Angiomyolipomas: a long-term follow-up study and a systematic reviewbenign liver tumorMesenchymal tumor1001981510019818NL-OMON44998Erasmus MC, Universitair Medisch Centrum Rotterdam9
已完成
不适用
Artemether in the treatment of Fasciola hepatica and/or Fasciola gigantica infections in EgyptISRCTN10372301Swiss Tropical Institute (Switzerland)40
招募中
不适用
Safety and efficacy study of four weeks oral administration of tolvaptan in liver cirrhotic patients with hyponatremia and ascitesDiseases of the digestive systemKCT0000569Konkuk University Medical Center104